Tomer Kariv's Net Worth
$39.7 Million
Who is Tomer Kariv?
Tomer Kariv has an estimated net worth of $39.7 Million. This is based on reported shares across multiple companies, which include Keros Therapeutics, Inc., VBI Vaccines Inc/BC, LogicBio Therapeutics, Inc., 89bio, Inc., Eloxx Pharmaceuticals, Inc., and Arno Therapeutics, Inc.
SEC CIK
Tomer Kariv's CIK is 0001568077
Past Insider Trading and Trends
2013 was Tomer Kariv's most active year for acquiring shares with 28 total transactions. Tomer Kariv's most active month to acquire stocks was the month of September. 2020 was Tomer Kariv's most active year for disposing of shares, totalling 11 transactions. Tomer Kariv's most active month to dispose stocks was the month of March. 2019 saw Tomer Kariv paying a total of $5,800,000.00 for 1,565,540 shares, this is the most they've acquired in one year. In 2022 Tomer Kariv cashed out on 14,352 shares for a total of $0.71, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Keros Therapeutics, Inc. (KROS) Snapshot price: $51.55
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 6
| |||
Form 4
| -0.15% | -7.18K |
—
| -$0.71 | 4.63M |
Nov 29
| |||
Form 3/A
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 1
| |||
Form 4
| +1.27% | 60K |
$50.00 | $3,000,000.00 | 4.79M |
Nov 17
| |||
Form 4
| +31.88% | 3.98M |
$16.00 | $6,999,984.00 | 16.48M |
Apr 13
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
VBI Vaccines Inc/BC (VBIV) Snapshot price: $0.649899
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 31
| |||
Form 4
| +62.24% | 1.43M |
$1.40 | $1,999,999.40 | 3.72M |
Dec 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 23
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
LogicBio Therapeutics, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 19
| |||
Form 4
|
∞
| 1.79M |
$10.00 |
—
| 1.79M |
Oct 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 18
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
89bio, Inc. (ETNB) Snapshot price: $8.22
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 1.13M |
$16.00 |
—
| 1.13M |
Nov 11 - Nov 13
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Eloxx Pharmaceuticals, Inc. (ELOX) Snapshot price: $0.82125
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 19
| |||
Form 4
| +275.43% | 5.93M |
$1.35 | $7,999,998.75 | 8.08M |
May 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 20
| |||
Form 4
| +10.25% | 200K |
$9.00 | $1,800,000.00 | 2.15M |
Jun 24
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 29
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 15
| |||
Form 4
| +21.85% | 350K |
$9.75 | $3,412,500.00 | 1.95M |
Apr 30
| |||
Form 4
| +0.40% | 12.6K |
$7.78 | $97,830.00 | 3.2M |
Mar 21 - Mar 22
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||